期刊文献+

一种新型西地那非衍生物的Q-TOF-MS鉴定 被引量:17

Identification of a new sildenafil analogue based on Q-TOF-MS
原文传递
导出
摘要 非法添加于中成药和保健食品中的西地那非类药物可严重危害健康,新型衍生物层出不穷。基于高分辨四级杆串联飞行时间质谱(Q-TOF-MS)方法,在保健食品中检出一种新型西地那非衍生物。该化合物经制备液相分离纯化,核磁共振确证结构,化学名为1-[4-丙氧基-3-[5-(6,7-二氢-1-甲基-7-氧代-3-丙基-1H-吡唑并[4,3d]嘧啶)]苯磺酰]-4-甲基哌嗪,即西地那非苯环上乙氧基衍生为丙氧基,国内未见报道。总结该结构类型的质谱行为规律,可有效帮助此类衍生物的快速结构鉴定。 The drugs such as sildenafil adulterated in herbal products and dietary supplements may endanger human health. The number of the new modified derivatives is increasing recently. Based on Q-TOF-MS, a new sildenafil analogue was found. It was isolated and purified by preparative liquid chromatography. Its structure was determined by NMR, as 1-[4-propoxy-3-(6, 7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4, 3-d] pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine. Compared with sildenafil, the ethoxy group of the benzene ring moiety was moved to the propoxy group, which had not been reported in China. The mass spectrometric behavior pattern of the structure type was summarized, which can greatly accelerate the structural analysis of novel analogues.
出处 《药学学报》 CAS CSCD 北大核心 2014年第4期513-516,共4页 Acta Pharmaceutica Sinica
关键词 西地那非衍生物 高分辨四级杆串联飞行时间质谱 非法添加 sildenafil analogue Q-TOF-MS adulteration
  • 相关文献

参考文献2

二级参考文献14

  • 1Brock GB,McMahon CG,Chen KK,et al.Efficacy and safety of tadalafil for the treatment of erectile dysfunction:results of integrated analyses[J].J Urol,2002,168(4 Pt 1):1332-1336.
  • 2Saenz de Tejada I,Anglin G,Knight JR,et al.Effects of tadalafil on erectile dysfunction in men with diabetes[J].Diabetes Care,2002,25(12):2159-2164.
  • 3Eardley I.New oral therapies for the treatment of erectile dysfunction[J].Br J Urol,1998,81 (1):122-127.
  • 4Truss MC,Stief CG.Phosphodiesterase inhibitors in the treatment of erectile dysfunction[J].Drugs Today,1998,34 (9):805 -812.
  • 5de Tejada IS.Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat[J].Int J Impot Res,2004,16 Suppl 1:S40-S42.
  • 6GRESSER U, GLEITER C H. Erectile dysfunction: Comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil , vard?enafil and tadalafil--review of the literature[J]. Eur 1 Med Res, 2002,7(10) :435446.
  • 7FEENSTRAJ, V AN D RJ, LACLE C F, et al. Acute myocardial infarction associated with silrlenafil[J]. Lancet, 1998, 352 (9132) :957 -958.
  • 8MORIYASU T, SHIGEOKA S, KISHIMOTO K,et al. Identifica?tion system for sildenafil in health foods[J]. Yakugaku Zasshi, 2001, 121 (2001) : 765-769.
  • 9SACRE P Y, DECONINCK E, CHIAP P, et al. Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines[J]. lChromatogrA, 2011,1218(37):6439-6447.
  • 10MANS DJ, CALLAHAN RJ, DUNNJ D, et al. Rapid-screening detection of acetildenafils, sildenafils and avanafil by ion mohility spectrometry[J]. 1 Pharm Biomed Anal, 2013, 75: 153-157.

共引文献35

同被引文献154

引证文献17

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部